investor harm

Class action lawsuit filed against Ardent Health for alleged $57.5M EBITDA overstatement and revenue misstatements tied to new accounting systems and sector headwinds.

Class action lawsuit filed against $UGXY alleging securities fraud related to setrusumab clinical trial data. Investors from August 2023 to December 2025 eligible.

Class action lawsuit filed against BellRing Brands alleging materially false statements about sales performance driven by inventory buildup rather than genuine demand.

Class action filed against $FRMI alleging materially false statements about Project Matador tenant demand and overstated financial prospects since October 2025 IPO.

Law firm sues Plug Power for allegedly misrepresenting DOE loan prospects and hydrogen facility viability, claiming investor harm through false statements.

Corcept Therapeutics faces securities lawsuit alleging misrepresentation of relacorilant clinical data and FDA approval prospects, while withholding known regulatory risks from investors.

Ramaco Resources faces class action lawsuit alleging executives made false statements about Brook Mine operations, claiming mining activity had commenced when it hadn't.

Class action lawsuit filed against agilon health for allegedly making false statements about 2026 financial guidance and misrepresenting risk reduction initiatives' financial impact.

Class action lawsuit filed against Snowflake for allegedly making misleading statements about business impact while concealing product efficiency changes and pricing adjustments between June 2023 and February 2024.

Varonis Systems faces class action lawsuit for allegedly making false statements about SaaS conversion capabilities, causing inflated stock prices during February-October 2025.

AMC faces class action lawsuit alleging it misled investors about Preferred Equity Unit rights, excluding APE holders from a 2023 dividend distribution through undisclosed technical loopholes.

Lakeland Industries faces class action lawsuit alleging executives made false statements about business performance, concealing shipping delays, production issues, and tariffs affecting Pacific Helmets and Jolly segments.

Ardent Health faces class action lawsuit for overstating Q3 2025 revenue and EBITDA guidance by $57.5 million due to inadequate accounting assessments and cost pressures.

Fermi Inc. faces securities class action over alleged false statements regarding Project Matador campus development and undisclosed single-tenant dependency risks.

Class action lawsuit filed against China Liberal Education for alleged pump-and-dump scheme. Shareholders who bought stock January 2025-2026 can seek recovery; lead plaintiff deadline is March 31, 2026.

BellRing Brands faces class action lawsuit alleging it misrepresented sales performance by failing to disclose that revenue growth was driven by customer inventory buildup rather than organic demand.

BellRing Brands faces class action lawsuit alleging it misrepresented sales growth as organic demand when it actually stemmed from customer inventory restocking following supply chain disruptions.

PayPal faces class action lawsuit alleging executives made false statements about revenue projections and 2027 financial targets, failing to disclose material risks to investors.

Kyndryl faces class action lawsuit alleging false financial statements and internal control weaknesses from August 2024 to February 2026, affecting investors who purchased securities during this period.

Class action lawsuit filed against Vistagen Therapeutics for alleged false statements regarding drug trial data. Investors who purchased securities April 2024-December 2025 may be eligible.